- Home
- NVRO vs LFCR Comparison
NVRO vs LFCR Comparison
Compare NVRO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- LFCR
- Stock Information
- Founded
- NVRO 2006
- LFCR 1986
- Country
- NVRO United States
- LFCR United States
- Employees
- NVRO N/A
- LFCR N/A
- Industry
- NVRO Medical/Dental Instruments
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- NVRO Health Care
- LFCR Health Care
- Exchange
- NVRO Nasdaq
- LFCR Nasdaq
- Market Cap
- NVRO 214.2M
- LFCR 218.8M
- IPO Year
- NVRO 2014
- LFCR N/A
- Fundamental
- Price
- NVRO $5.73
- LFCR $5.61
- Analyst Decision
- NVRO Hold
- LFCR Buy
- Analyst Count
- NVRO 12
- LFCR 3
- Target Price
- NVRO $7.24
- LFCR $8.00
- AVG Volume (30 Days)
- NVRO 1.7M
- LFCR 127.0K
- Earning Date
- NVRO 02-28-2025
- LFCR 01-02-2025
- Dividend Yield
- NVRO N/A
- LFCR N/A
- EPS Growth
- NVRO N/A
- LFCR N/A
- EPS
- NVRO N/A
- LFCR N/A
- Revenue
- NVRO $419,146,000.00
- LFCR $130,858,000.00
- Revenue This Year
- NVRO N/A
- LFCR $2.24
- Revenue Next Year
- NVRO $0.23
- LFCR $7.88
- P/E Ratio
- NVRO N/A
- LFCR N/A
- Revenue Growth
- NVRO N/A
- LFCR 16.47
- 52 Week Low
- NVRO $3.17
- LFCR $3.68
- 52 Week High
- NVRO $16.12
- LFCR $8.45
- Technical
- Relative Strength Index (RSI)
- NVRO 70.16
- LFCR 38.75
- Support Level
- NVRO $4.77
- LFCR $5.59
- Resistance Level
- NVRO $5.80
- LFCR $6.39
- Average True Range (ATR)
- NVRO 0.13
- LFCR 0.29
- MACD
- NVRO -0.01
- LFCR 0.01
- Stochastic Oscillator
- NVRO 93.20
- LFCR 2.50
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.